Chair, Scientific Advisory Committee

Prof Ashley Dunn became Head of the Molecular Biology Program at the Ludwig Institute for Cancer Research (Melbourne) in 1982. Two years later he and colleagues molecularly cloned GM-CSF, a cytokine used to aid recovery of bone marrow in cancer patients following chemotherapy treatment.

He served as Associate Director of the Institute until 2004, is currently a Professorial Fellow of the Department of Surgery at the University of Melbourne and serves on several scientific advisory boards.